Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages

Nitric oxide (NO) plays an important role in resistance to Mycobacterium tuberculosis infection. Our aim was to determine whether inducible NO synthase (iNOS) expression and generation of reactive nitrogen intermediates (RNI) by alveolar macrophages (AM) are increased in patients infected with M. tuberculosis. NO levels in the exhaled air of 19 active pulmonary tuberculosis (TB) and 14 control subjects were measured using a chemiluminescence NO analyser. The expression of iNOS on AM was studied by labelling AM with anti-mac iNOS polyclonal antibody analysed with a flow cytometer. The spontaneous generation of RNI by cultured AM was also measured. Data are presented as mean+/-SEM. The level of NO in exhaled air was higher in patients with active TB (16.2+/-1.2 parts per billion (ppb)) compared to control subjects (6.5+/-0.9 ppb), p<0.0001. Exhaled NO decreased with anti-TB treatment. Compared to control subjects (29.0+/-4.5 fluorescence intensity (FI)), iNOS expression on AM was upregulated in TB patients (86.3+/-12.5 FI) p<0.001 and the capacity for spontaneous generation of nitrite was enhanced. Nitrite production was inhibited by N(G)-monomethyl-L-arginine (L-NMMA), a competitive inhibitor of iNOS. The expression of iNOS on AM was related to the concentration of exhaled NO (r=0.66, p<0.001) and the nitrite generation capacity of AM (r(s)=0.77, p<0.001). We conclude that the increase in exhaled nitric oxide observed in patients with active pulmonary tuberculosis is due to an upregulation of inhaled NO synthase expression in alveolar macrophages which have an enhanced capacity for nitric oxide production.

This article has been cited by other articles:

				L. Kobzik Translating NO Biology into Clinical Advances: Still Searching for the Right Dictionary? Am. J. Respir. Cell Mol. Biol., July 1, 2009; 41(1): 9 - 13. [Full Text] [PDF]

				A. S. Almeida, P. M. Lago, N. Boechat, R. C. Huard, L. C. O. Lazzarini, A. R. Santos, M. Nociari, H. Zhu, B. M. Perez-Sweeney, H. Bang, et al. Tuberculosis Is Associated with a Down-Modulatory Lung Immune Response That Impairs Th1-Type Immunity J. Immunol., July 1, 2009; 183(1): 718 - 731. [Abstract] [Full Text] [PDF]

				G. Rodway, J Choi, L. Hoffman, and J. Sethi Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications Chronic Respiratory Disease, February 1, 2009; 6(1): 19 - 29. [Abstract] [PDF]

				K. G. Lim and C. Mottram The Use of Fraction of Exhaled Nitric Oxide in Pulmonary Practice Chest, May 1, 2008; 133(5): 1232 - 1242. [Abstract] [Full Text] [PDF]

				J. Andersson, A. Samarina, J. Fink, S. Rahman, and S. Grundstrom Impaired Expression of Perforin and Granulysin in CD8+ T Cells at the Site of Infection in Human Chronic Pulmonary Tuberculosis Infect. Immun., November 1, 2007; 75(11): 5210 - 5222. [Abstract] [Full Text] [PDF]

				D. F. Warner and V. Mizrahi Tuberculosis Chemotherapy: the Influence of Bacillary Stress and Damage Response Pathways on Drug Efficacy Clin. Microbiol. Rev., July 1, 2006; 19(3): 558 - 570. [Abstract] [Full Text] [PDF]

				J. Choi, L. A. Hoffman, G. W. Rodway, and J. M. Sethi Markers of lung disease in exhaled breath: nitric oxide. Biol Res Nurs, April 1, 2006; 7(4): 241 - 255. [Abstract] [PDF]

				S Stenger Immunological control of tuberculosis: role of tumour necrosis factor and more Ann Rheum Dis, November 1, 2005; 64(suppl_4): iv24 - iv28. [Abstract] [Full Text] [PDF]

				R. A. Cox and D. M. Magee Coccidioidomycosis: Host Response and Vaccine Development Clin. Microbiol. Rev., October 1, 2004; 17(4): 804 - 839. [Abstract] [Full Text] [PDF]

				D. Ziora, K. Kaluska, and J. Kozielski An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis Eur. Respir. J., October 1, 2004; 24(4): 609 - 614. [Abstract] [Full Text] [PDF]

				C Lane, D Knight, S Burgess, P Franklin, F Horak, J Legg, A Moeller, and S Stick Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath Thorax, September 1, 2004; 59(9): 757 - 760. [Abstract] [Full Text] [PDF]

				M. G. Bonecini-Almeida, J. L. Ho, N. Boechat, R. C. Huard, S. Chitale, H. Doo, J. Geng, L. Rego, L. C. O. Lazzarini, A. L. Kritski, et al. Down-Modulation of Lung Immune Responses by Interleukin-10 and Transforming Growth Factor {beta} (TGF-{beta}) and Analysis of TGF-{beta} Receptors I and II in Active Tuberculosis Infect. Immun., May 1, 2004; 72(5): 2628 - 2634. [Abstract] [Full Text] [PDF]

				W. R. Waters, M. V. Palmer, D. L. Whipple, M. P. Carlson, and B. J. Nonnecke Diagnostic Implications of Antigen-Induced Gamma Interferon, Nitric Oxide, and Tumor Necrosis Factor Alpha Production by Peripheral Blood Mononuclear Cells from Mycobacterium bovis-Infected Cattle Clin. Vaccine Immunol., September 1, 2003; 10(5): 960 - 966. [Abstract] [Full Text] [PDF]

				P. Escalante, P. T. Cagle, E. D. Chan, and C. Cool Nitric oxide and tuberculosis infection Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1718 - 1718. [Full Text] [PDF]

				T. Schon, D. Elias, F. Moges, E. Melese, T. Tessema, O. Stendahl, S. Britton, and T. Sundqvist Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis Eur. Respir. J., March 1, 2003; 21(3): 483 - 488. [Abstract] [Full Text] [PDF]

				K. R. Morris, R. D. Lutz, H.-S. Choi, T. Kamitani, K. Chmura, and E. D. Chan Role of the NF-{kappa}B Signaling Pathway and {kappa}B cis-Regulatory Elements on the IRF-1 and iNOS Promoter Regions in Mycobacterial Lipoarabinomannan Induction of Nitric Oxide Infect. Immun., March 1, 2003; 71(3): 1442 - 1452. [Abstract] [Full Text] [PDF]

				C. Nathan Inducible Nitric Oxide Synthase in the Tuberculous Human Lung Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 130 - 131. [Full Text] [PDF]

				M. A. Firmani and L. W. Riley Mycobacterium tuberculosis CDC1551 Is Resistant to Reactive Nitrogen and Oxygen Intermediates In Vitro Infect. Immun., July 1, 2002; 70(7): 3965 - 3968. [Abstract] [Full Text] [PDF]

				D.V. Pechkovsky, G. Zissel, C. Stamme, T. Goldmann, H. Ari Jaffe, M. Einhaus, C. Taube, H. Magnussen, M. Schlaak, and J. Muller-Quernheim Human alveolar epithelial cells induce nitric oxide synthase-2 expression in alveolar macrophages Eur. Respir. J., April 1, 2002; 19(4): 672 - 683. [Abstract] [Full Text] [PDF]

				C. A. Scanga, V. P. Mohan, K. Tanaka, D. Alland, J. L. Flynn, and J. Chan The Inducible Nitric Oxide Synthase Locus Confers Protection against Aerogenic Challenge of Both Clinical and Laboratory Strains of Mycobacterium tuberculosis in Mice Infect. Immun., December 1, 2001; 69(12): 7711 - 7717. [Abstract] [Full Text] [PDF]

				E. D. Chan, J. Chan, and N. W. Schluger What is the Role of Nitric Oxide in Murine and Human Host Defense against Tuberculosis? . Current Knowledge Am. J. Respir. Cell Mol. Biol., November 1, 2001; 25(5): 606 - 612. [Abstract] [Full Text] [PDF]

				S. A. KHARITONOV and P. J. BARNES Exhaled Markers of Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722. [Full Text] [PDF]

				E. D. Chan, K. R. Morris, J. T. Belisle, P. Hill, L. K. Remigio, P. J. Brennan, and D. W. H. Riches Induction of Inducible Nitric Oxide Synthase-NO{middle dot} by Lipoarabinomannan of Mycobacterium tuberculosis Is Mediated by MEK1-ERK, MKK7-JNK, and NF-{kappa}B Signaling Pathways Infect. Immun., April 1, 2001; 69(4): 2001 - 2010. [Abstract] [Full Text] [PDF]

				G.A.W. Rook, G. Seah, and A. Ustianowski M. tuberculosis: immunology and vaccination Eur. Respir. J., March 1, 2001; 17(3): 537 - 557. [Abstract] [Full Text] [PDF]

				C. Nathan and M. U. Shiloh Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens PNAS, August 1, 2000; 97(16): 8841 - 8848. [Abstract] [Full Text] [PDF]

				H. DUPLAIN, C. SARTORI, M. LEPORI, M. EGLI, Y. ALLEMANN, P. NICOD, and U. SCHERRER Exhaled Nitric Oxide in High-Altitude Pulmonary Edema . Role in the Regulation of Pulmonary Vascular Tone and Evidence for a Role against Inflammation Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 221 - 224. [Abstract] [Full Text]

				Y. Tian, Y. Xing, R. Magliozzo, K. Yu, B. R. Bloom, and J. Chan A Commercial Preparation of Catalase Inhibits Nitric Oxide Production by Activated Murine Macrophages: Role of Arginase Infect. Immun., May 1, 2000; 68(5): 3015 - 3018. [Abstract] [Full Text] [PDF]

				O. Aikio, K. Vuopala, M.-L. Pokela, and M. Hallman Diminished Inducible Nitric Oxide Synthase Expression in Fulminant Early-Onset Neonatal Pneumonia Pediatrics, May 1, 2000; 105(5): 1013 - 1019. [Abstract] [Full Text]

				H.-P. KUO, C.-H. WANG, K.-S. HUANG, H.-C. LIN, C.-T. YU, C.-Y. LIU, and L.-C. LU Nitric Oxide Modulates Interleukin-1beta and Tumor Necrosis Factor-alpha Synthesis by Alveolar Macrophages in Pulmonary Tuberculosis Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 192 - 199. [Abstract] [Full Text]

				B. D. Johnson, K. C. Beck, R. J. Zeballos, and I. M. Weisman Advances in Pulmonary Laboratory Testing Chest, November 1, 1999; 116(5): 1377 - 1387. [Abstract] [Full Text] [PDF]

				S. SINGH, S J. WORT, and T. W EVANS Inducible nitric oxide and pulmonary infection Thorax, November 1, 1999; 54(11): 959 - 960. [Full Text]

				H. E. Marshall and J. S. Stamler Exhaled Nitric Oxide (NO), NO Synthase Activity, and Regulation of Nuclear Factor (NF)-kappa B Am. J. Respir. Cell Mol. Biol., September 1, 1999; 21(3): 296 - 297. [Full Text]

				K F Chung and P J Barnes Cytokines in asthma Thorax, September 1, 1999; 54(9): 825 - 857. [Full Text]

				J. M. Hickman-Davis, P. O'Reilly, I. C. Davis, J. Peti-Peterdi, G. Davis, K. R. Young, R. B. Devlin, and S. Matalon Killing of Klebsiella pneumoniae by human alveolar macrophages Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L944 - L956. [Abstract] [Full Text] [PDF]